Fido Therapeuticssp. z o.o.
Research and experimental development in social sciences and humanities
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2023-06-05
Share capital
5 000,00 PLN
Registered address
ul. Aleksandra Ostrowskiego 30B, 53-238 Wrocław, Poland
Financials
Revenue history
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 502.26MedianUSD 42.48kAverageUSD 670.80k
Net profit
This companyUSD -53.05kMedianUSD 382.38AverageUSD 47.73k
Operating costs
This companyUSD 53.55kMedianUSD 38.11kAverageUSD 612.98k
Assets
This companyUSD 125.03kMedianUSD 26.61kAverageUSD 405.39k
Industry
Bank accounts
Registered as a VAT taxpayer on 2024-04-05. Active
33 1090 2590 0000 0001 5449 0430
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Jarosław Maciej Michałowski — Management Board Member
Stanisław Maria Karkosz — Management Board Member
Norbert Szczepaniak — President of the Management Board
Manner of representation
Each member of the management board is authorized to independently represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Stanisław Maria Karkosz (31) | 24 | $324.15 | 24% |
Jarosław Maciej Michałowski (50) | 24 | $324.15 | 24% |
| 24 | $324.15 | 24% | |
Norbert Szczepaniak (35) | 24 | $324.15 | 24% |
Others | 4 | $54.02 | 4% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Stanisław Maria Karkosz (31) | Shareholder of a limited liability company, 1200.0 PLN | |
Jarosław Maciej Michałowski (50) | Shareholder of a limited liability company, 1200.0 PLN | |
Norbert Szczepaniak (35) | Shareholder of a limited liability company, 1200.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Instytut Analiz i Ekspertyz Gospodarczychsp. z o.o. | $59,294.27 | iaeg.pl | ||
| Polski Instytut Jakościsp. z o.o. | $45,846.31 | instytutjakosci.com | ||
| Hrmapasp. z o.o. | $42,788.97 | hrmapa.pl | ||
| Centrum Transferu Wiedzy Akademii Pedagogiki Specjalnej Im. Marii Grzegorzewskiejsp. z o.o. | $24,580.31 | aps.edu.pl | ||
| Centrum Rozwoju Społeczno-Gospodarczego Przedsiębiorstwo Społecznesp. z o.o. | $24,346.47 | crsg.pl | ||
| ENIF StarP.S.A. | $19,651.79 | enifstar.com | ||
| Gdański Kantor Sztukisp. z o.o. | $8,009.39 | zeidler.pl | ||
| MotoplexP.S.A. | $5,234.21 | motoplex.pl | ||
| KMJsp. z o.o. | $5,565.54 | kmj24.pl | ||
| Centrum Informacji Publicznejsp. z o.o. | — | cip.pl |
FAQ
The main business activity of Fido Therapeutics focuses on research and experimental development in social sciences and humanities.
The company was registered in the Polish National Court Register (KRS) on June 5, 2023.
The headquarters is located at: ul. Aleksandra Ostrowskiego 30B, 53-238 Wrocław.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $502, representing an increase of 50920.4% compared to 2024.
No, the company recorded a net loss of $53,050 in 2025. For comparison, in 2024 the loss was $89,229, meaning the company reduced its loss by 40.7%.
The largest operating cost category falls under depreciation and amortization. This category amounted to $53,155 in 2025, representing 99% of all operating expenses.
Last updated: 2026-07-15